Avignonet Lauragais, France

Pascual Ferrara

USPTO Granted Patents = 12 


Average Co-Inventor Count = 4.9

ph-index = 5

Forward Citations = 158(Granted Patents)


Location History:

  • Vilefranche de Lauragais, FR (1996)
  • Villefranche de Lauragais, FR (1995 - 1999)
  • Saint Léon. Haute-Garonne, FR (2009)
  • Avignolet Lauragais, FR (2000 - 2011)
  • Avignonet Lauragais, FR (2001 - 2012)

Company Filing History:


Years Active: 1995-2012

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Pascual Ferrara: Innovator in Antibody Research

Introduction

Pascual Ferrara is a notable inventor based in Avignonet Lauragais, France. He has made significant contributions to the field of antibody research, holding a total of 12 patents. His work focuses on the development of innovative solutions in the medical and biotechnological sectors.

Latest Patents

Among his latest patents are the IL-13 receptor antibodies, which pertain to monoclonal and polyclonal antibodies capable of specifically recognizing the IL-13 receptor α and their various uses. Another significant invention is the purified polypeptides having IL-13 receptor activity, which involves a purified polypeptide comprising an amino acid sequence chosen from the sequence SEQ ID NO:4 or biologically active amino acid sequences derived from SEQ ID NO:4.

Career Highlights

Pascual Ferrara has had a distinguished career, working with prominent companies such as Sanofi and Sanofi-Aventis. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Throughout his career, Pascual has collaborated with esteemed colleagues, including Daniel Caput and Natalio Vita. These partnerships have further enhanced his research capabilities and innovation potential.

Conclusion

Pascual Ferrara's work in antibody research exemplifies the impact of innovation in the medical field. His patents and collaborations reflect a commitment to advancing scientific knowledge and improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…